Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

A Novel Therapy for the Treatment of Pyoderma Gangrenosum

Azizan N.Z., and Gangaram, H.B., and Hussein S.H., (2008) A Novel Therapy for the Treatment of Pyoderma Gangrenosum. Medical Journal of Malaysia, 63 (1). pp. 51-54. ISSN 0300-5283

Full text not available from this repository.

Affiliations

Hospital Kuala Lumpur. Dept. of Dermatology.
Hospital Kuala Lumpur. Dept. of Dermatology.
Hospital Kuala Lumpur. Dept. of Dermatology.

Abstract

Pyoderma gangrenosum (PG) is an uncommon, chronic, painful, ulcerative skin disease of unknown origin, often associated with systemic diseases, including inflammatory bowel disease, rheumatoid arthritis, monoclonal gammopathy, hepatitis and myeloproliferative disorders. The mainstay of therapy for PG has been high dose corticosteroids but not all patients have a favourable outcome. Other systemic agents have also been used such as cyclosporine, azathioprine, cyclosphamide and tacrolimus. However, all these systemic therapies can be complicated by serious side effects. In this Paper, we report a series of four patients with pyoderma gangrenosum treated successfully with topical cyclosporine. No side effects were observed in any of the patients and there was minimal systemic absorption of the topical cyclosporine.

Item Type:Journal
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:4256

1. Brunsting LA, Goeckermao wH, O’ Leary PA. Pyoderma gangrenosum: clinical and experimental observations in five cases occuring in adults. Arch Dermatol 1930; 22: 655-80.

2. Curley R.K., Macfarlane A.W. Pyoderma gangrenosum treated with cyclosporine. Br J Dermatol 1985; 113: 601-604.

3. Powell FC, Su WPD et al. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996; 34: 395-409.

4. Powell FC, Collins S. Pyoderma gangrenosum. Clinics in Dermatol. 2001; 18: 283-93.

5. Chow RKP, Ho VC. Treatment of pyoderma gangrenosum. J Am Acad Dermatol 1996; 34: 1047-60.

6. Eichhorn PJ. Pyoderma gangrenosum. Dermatol Therapy 2001; 14: 102-10.

7. Reichrath J, Bens G, Bonowitz A. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005; 53: 273-83.

8. O’Donnell B, Powell FC. Cyclosporine treatment of pyoderma gangrenosum. J Am Acad Dermatol 1991; 24: 141-3.

9. Matis W, Ellis CN, Griffiths CEM. Treatment of pyoderma gangrenosum with cyclosporine Arch Dermatol 1992; 128: 1060-64.

10. Mroweitz U, Christophers E. Clearing of pyoderma gangrenosum by intralesional cyclosporine. Br J Dermatol 1991; 125: 499.

11. Eisen D, Ellis C. Topical cyclosporine for oral disorders. J Am Acad Dermatol 1990; 23: 1259-64.

12. Schuppe HC, Homey B et al. Topical tacrolimus for pyoderma gangrenosum. Lancet 1998; 351: 832.

13. Ghislain PD, Decker ID, Marot L, Lachapelle JM. Efficacy and systemic absorption of topical tacrolimus used in pyoderma gangrenosum. Br J Dermatol 2004; 150: 1052-53.

14. Kontos AP, Kerr HA, Fivenson D, Remishofsky C, Jacobsen G. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum. Int J Dermatol 2006; 45: 1383-85.

15. Richter-Hintz D, Schuppe HC et al. Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol 2000 42: 304.

16. Gupta AK. Tacrolimus:a review of its use for the management of dermatoses. J Europ Acad Dermatol Venerol 2002; 16: 100-14.

17. Ho VC, Griffifths CEM, Ellis CN et al. Intralesional cyclosporine in the treatment of psoriasis. J Am Acad Dermatol 1990; 22: 94-100.

Repository Staff Only: item control page